Jardiance® (empagliflozin) becomes the first and only approved treatment in Europe for adults with symptomatic chronic heart failure regardless of ejection fraction
As a family-owned company Boehringer Ingelheim is governed by the Board of Managing Directors composed of five members. Read more about their respective responsibilities.
What is happening behind the doors of congress centers? How do patients benefit from the participation of pharmaceutical representatives? Let’s shed some light.